Anxiety and substance use disorders: A review

Psychiatric Times

Volumn 25, Issue 10 SUPPL. 3, 2008, Pages 19-23

  Smith, Joshua P ^a   Book, Sarah W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55549111902     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Kessler RC, Berglund P, Demier O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. [Published erratum in Arch Gen Psychiatry. 62(7)768.] Arch Gen Psychiatry. 2005;62(6):593-602 [see comments].
2. Kushner MG, Krueger R, Frye B, Peterson J. Epidemiological perspectives on co-occurring anxiety disorder and substance use disorder. In: Stewart SH, Conrad PJ, eds. Anxiety and Substance Use Disorders: The Vicious Cycle of Comorbidity. New York: Springer; 2008:3-17.
3. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry. 1990;147(6):685-695 [comment].
4. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(5):566-576.
5. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830-842.
6. Stewart SH, Conrad PJ. Anxiety disorders and substance use disorders co-morbidity: common themes and future directions. In: Stewart SH, Conrad PJ, eds. Anxiety and Substance Use Disorders: The Vicious Cycle of Comorbidity. New York: Springer; 2008:239-257.
7. Grant BF, Stinson FS, Dawson DA et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816.
8. Driessen M, Meier S, Hill A et al. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol. 2001;36(3):249-255.
9. Johnston AL, Thevos AK, Randall CL, Anton RF. Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis. Br J Addict. 1991;86(6):719-725.
10. Sannibale C, Hall W. Gender-related symptoms and correlates of alcohol dependence among men and women with a lifetime diagnosis of alcohol use disorders. Drug Alcohol Rev. 2001;20(4):369-383.
11. Perkonigg A, Settele A, Pfister H et al. Where have they been? Service use of regular substance users with and without abuse and dependence. Soc Psychiatry Psychiatr Epidemiol. 2006;41(6):470-479.
12. Thomas SE, Thevos AK, Randall CL. Alcoholics with and without social phobia: a comparison of substance use and psychiatric variables. J Stud Alcohol. 1999;60(4):472-479.
13. Bruce SE, Yonkers KA, Otto MW et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162(6):1179-1187.
14. Hornig CD, McNally RJ. Panic disorder and suicide attempt. A reanalysis of data from the Epidemiologic Catchment Area study. Br J Psychiatry. 1995;167(1):76-79.
15. Randall CL, Johnson MR, Thevos AK et al. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety. 2001;14(4):255-262.
16. Book SW, Thomas SE, Randall PK, Randall CL. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. J Anxiety Disord. 2008;22(2):310-318.
17. Thomas SE, Randall PK, Book SW, Randall CL. A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res. 2008;32(1):77-84.
18. Brady KT, Sonne S, Anton RF et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005;29(3):395-401.
19. Kranzler HR, Burleson JA, Del Boca FK et al. Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Arch Gen Psychiatry. 1994;51(9)720-731.
20. Johnson BA, Ait-Daoud N, Bowden CL et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003;361(9370):1677-1685 [see comments].
21. Johnson BA, Rosenthal N, Capece JA et al.; Topiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study Group. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007;298(14):1641-1651 [see comments].
22. Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs. 2005;19(10):873-896.
23. Tucker P, Trautman RP, Wyatt DB et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 68(2):201-206.
24. Van Ameringen M, Mancini C, Pipe B et al. An open trial of topiramate in the treatment of generalized social phobia. J Clin Psychiatry. 2004;65(12):1674-1678.
25. Rubio G, Jimenez-Arriero MA, Martinez-Gras I et al. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder. J Clin Psychopharmacol. 2006;26(3):341-344 [letter].
26. Dunlop BW, Papp L, Garlow SJ et al. Tiagabine for social anxiety disorder. Hum Psychopharmacol. 2007;22(4):241-244.
27. Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol. 2007;27(3):263-272.
28. Gonzalez G, Desai R, Sofuoglu M et al. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007;87(1):1-9.
29. Winhusen T, Somoza E, Ciraulo DA et al. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Drug Alcohol Depend. 2007;91(2-3):141-148.
30. Pagano ME, Book SW, Onder CC et al. Alcoholics seeking treatment: does co-occurring social anxiety disorder interfere with AA affiliation? Poster presented at the 2008 RSA/ISBRA Joint Scientific Meeting. Washington, D.C.; June 28-July 2, 2008.
31. Zvolensky MJ, Bernstein A, Yartz AR et al. Cognitive-behavioral treatment of co-morbid panic psychopathology and tobacco use and dependence. In: Stewart SH, Conrod PJ, eds. Anxiety and Substance Use Disorders: The Vicious Cycle of Comorbidity. New York: Springer; 2008.
32. Brady KT, Dansky BS, Back SE et al. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings. J Subst Abuse Treat. 2001;21(1):47-54.
33. Riggs DS, Foa EB. Treatment for co-morbid posttraumatic stress disorder and substance use disorders. In: Stewart SH, Conrod PJ, eds. Anxiety and Substance Use Disorders: The Vicious Cycle of Comorbidity. New York: Springer; 2008.
34. Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol Clin Exp Res. 2001;25(2):210-220.
35. Prochaska JO, DiClemente CC. The transtheoretical approach. In: Norcross JC, Goldfried MR, eds. Handbook of Psychotherapy Integration. New York: Basic Books; 1992:300-334.
36. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd Ed. New York: Guilford Press; 2002.
37. Hien DA, Cohen LR, Miele GM et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004;161(8):1426-1432.